TokenPost topic
2 TokenPost stories are tagged Novo Nordisk. The newest appear first.
The 68-week estimate assumes uninterrupted treatment. A second analysis examined women classified by menopause status.
Oct 20, 2026, 4:52 PM EDT · Business
The agreement gives Novo Nordisk rights to use Nanexa’s technology across up to five injectable-drug programs, with potential upfront, milestone and royalty payments.
Sep 25, 2026, 6:02 AM EDT · Business